Although senile plaques—primarily composed of beta-amyloid (Aβ) peptides—and neurofibrillary tangles (NFTs)—formed by hyperphosphorylated tau protein—have been recognized as key features of AD for over a century [3], the molecular mechanisms driving the progression of the disorder are still not fully understood. The gene discussed is MAPT; the disease is Alzheimer disease.